Skip to main content

Tc-99m Sestamibi SPECT Myocardial Perfusion

By Troy Zhou, PhD, DABR, DABSNM
December 27, 2023 • 15 min read

Tc-99m sestamibi and Tc-99m tetrofosmin are the standard radiopharmaceuticals for single-photon myocardial perfusion imaging (MPI), the most widely used noninvasive test of coronary blood flow. Both tracers distribute in proportion to regional myocardial blood flow, are retained in viable myocytes with minimal redistribution, and emit the 140 keV photon that SPECT gamma cameras are optimized to detect.4

A technically sound MPI study is a chain of decisions: which tracer, which stress method, how much activity, what acquisition geometry, whether to gate, and how to correct for attenuation and scatter. Each link affects image quality, diagnostic accuracy, and patient dose. This guide covers the tracer physics, the protocols, gated SPECT, the dedicated CZT cameras that have reshaped the field, a worked dose calculation, and the regulatory context a nuclear medicine program must manage.12

Introduction

MPI answers a specific clinical question: is a region of myocardium receiving adequate blood flow at stress compared with rest? A perfusion defect that appears at stress and fills in at rest indicates ischemia; a fixed defect suggests infarction or scar. Because the test is noninvasive and prognostically powerful, it is a cornerstone of evaluating known or suspected coronary artery disease.12

The physics that makes it work is elegant. Technetium-99m decays by isomeric transition, emitting a 140 keV gamma photon — energetic enough to escape the body, low enough to collimate efficiently — with a physical half-life of about six hours that matches a clinical workflow. Attach that nucleus to a lipophilic cation that myocytes take up in proportion to flow, and the gamma camera can map perfusion.4

This article is written for the medical physicist and the nuclear cardiology team who must translate that physics into reliable, low-dose, defensible imaging. We cover the tracers, stress testing, acquisition and reconstruction, gated SPECT, CZT instrumentation, dosimetry with worked math, optimization, and the NRC and state framework that governs the radioactive material involved.

Topic Explanation

The tracers: how they map perfusion

Both sestamibi (methoxyisobutylisonitrile, Cardiolite) and tetrofosmin (Myoview) are lipophilic, monovalent cationic technetium-99m complexes. They diffuse across the sarcolemmal and mitochondrial membranes and are retained within myocyte mitochondria, driven by the negative mitochondrial membrane potential of viable cells. Uptake is therefore proportional both to regional blood flow at the time of injection and to tissue viability.4

Two properties define the imaging approach:

  • Minimal redistribution. Unlike thallium-201, these Tc-99m agents do not significantly redistribute after uptake. The image is a snapshot of perfusion at the moment of injection, so rest and stress each require a separate injection.4
  • Flow-dependent extraction with roll-off. First-pass myocyte extraction is moderate and declines at high flow rates, so the tracers progressively underestimate perfusion as hyperemic flow rises. This is a fundamental limitation of relative SPECT perfusion and a reason absolute flow quantification is better established with PET.14

Sestamibi and tetrofosmin share Tc-99m physics and the same uptake mechanism; their practical difference is clearance kinetics, with tetrofosmin generally clearing hepatobiliary and lung activity faster.

Stress: provoking the flow difference

A perfusion study compares rest to stress, and the stress must create a flow disparity between normal and stenosed territories. Options include:13

  • Exercise (treadmill or bicycle), preferred when the patient can achieve adequate workload because it adds functional information.
  • Vasodilator pharmacologic stress — regadenoson, adenosine, or dipyridamole — which increases flow in normal vessels more than in stenosed ones, exposing relative hypoperfusion.
  • Dobutamine, used when vasodilators are contraindicated.

The tracer is injected at peak stress; myocardial uptake then reflects the stress flow distribution, and because redistribution is minimal, imaging can follow after a short delay.

Acquisition and reconstruction

Conventional SPECT MPI uses a dual-head Anger camera with low-energy high-resolution collimators, acquiring projections over a 180° arc (typically 45° right-anterior-oblique to 45° left-posterior-oblique) through a 15–20% energy window centered on 140 keV. Images are reconstructed with iterative algorithms (ordered-subset expectation maximization) incorporating resolution recovery, with scatter and, increasingly, CT-based attenuation correction to reduce soft-tissue artifact.2

Key Technical Principles

Gated SPECT: perfusion plus function

ECG-gated SPECT bins counts into 8 or 16 frames across the cardiac cycle, yielding not only perfusion but also left ventricular ejection fraction (LVEF), end-diastolic and end-systolic volumes, and regional wall motion and thickening. Gating is also an artifact discriminator: a region with reduced counts but preserved systolic wall thickening is more likely attenuation artifact than true scar.2 Quantitative gated parameters are reproducible enough to be tracked over time and have been extended on modern cameras to additional remodeling indices.5

CZT cameras: a step change in sensitivity

Dedicated cardiac cameras built from cadmium-zinc-telluride (CZT) semiconductor detectors directly convert gamma photons to electrical charge, bypassing the scintillator-and-photomultiplier chain of an Anger camera. Combined with focused collimation and cardio-centric geometry, CZT systems deliver count sensitivity roughly 5 to 10 times that of conventional cameras, with improved energy and reconstructed spatial resolution.1 That sensitivity is spent in one of two ways: shorter acquisitions or lower administered activity. Dedicated-camera activity quantification is feasible when attenuation and scatter corrections are applied, although the CZT low-energy tail requires care in energy-based scatter correction.8

Dosimetry: the worked numbers

Effective dose from an administered activity is the product of the activity and the radiopharmaceutical's effective-dose coefficient :

Using ICRP Publication 128 adult effective-dose coefficients for Tc-99m sestamibi — about at rest and at stress — a conventional one-day protocol with 330 MBq at rest and 1110 MBq at stress gives:9

That result is consistent with the international survey mean effective dose for nuclear cardiology, which was about 9 mSv in most of the world and higher where best practices were not adopted.7 It also shows the dose-reduction opportunity: stress-only imaging drops the rest component entirely, and on CZT cameras with weight-based dosing (for example, 2.25 MBq per kilogram), stress-optional rest protocols have been reported at mean effective doses near 2.6 mSv without loss of prognostic value.6

Comparing the two tracers

Property Tc-99m sestamibi Tc-99m tetrofosmin
Chemical class Lipophilic cationic Tc-99m complex Lipophilic cationic Tc-99m complex
Photon energy / half-life 140 keV / ~6 h 140 keV / ~6 h
Uptake mechanism Mitochondrial membrane potential, flow-proportional Mitochondrial membrane potential, flow-proportional
Redistribution Minimal Minimal
Hepatobiliary clearance Slower (often longer wait to image) Faster (can allow earlier imaging)
ICRP 128 effective-dose coefficient (rest / stress) ~9.0 / 7.9 ×10⁻³ mSv/MBq ~7.6 / 7.0 ×10⁻³ mSv/MBq

Values for photon energy, half-life, and mechanism are shared tracer physics; the effective-dose coefficients are from ICRP Publication 128.49

Clinical Impact

MPI is used to diagnose coronary artery disease, to risk-stratify patients, and to guide revascularization decisions. A normal scan carries a low near-term event rate, while the extent and severity of reversible defects predict risk and benefit from intervention.12 Gated LVEF and volumes add independent prognostic information and help separate true disease from artifact.25

The field's trajectory has been toward lower dose without sacrificing accuracy. Stress-first and stress-only imaging, weight-based dosing, prone and upright positioning, attenuation correction, and CZT instrumentation have all contributed. International practice surveys found wide variation in dose for the same test and identified concrete, guideline-based steps — stress-only imaging, camera-based dose-reduction methods, and weight-adjusted activity — that bring programs in line with ALARA.67 For a nuclear cardiology laboratory, adopting these is both a quality and a radiation-protection imperative.

Practical Optimization Tips

Match the protocol to the patient and the question

  • Choose exercise stress when the patient can perform it; reserve pharmacologic stress for those who cannot or who have specific contraindications.1
  • Favor stress-first or stress-only imaging in appropriate patients; a normal high-quality stress study can obviate the rest injection and roughly halve the dose.67
  • Use weight-based administered activity rather than a fixed dose so that larger patients get adequate counts and smaller patients are not overexposed.6

Protect image quality

  • Verify energy-window centering at 140 keV and collimator selection before acquisition; use attenuation and scatter correction to reduce inferior-wall and breast artifacts.2
  • Always gate when feasible, and read perfusion alongside wall motion to separate artifact from true defect.2
  • On CZT systems, apply the manufacturer's scatter model that accounts for the low-energy tail when quantitative accuracy matters.8

Manage radiopharmaceutical quality and safety

  • Confirm radiochemical purity and the Tc-99m generator's performance as part of the hot-lab quality program before dosing patients.
  • Measure each unit dose in the dose calibrator and document it against the written directive and prescribed activity.

Regulatory Considerations

Because MPI uses byproduct material, it falls under NRC (or Agreement State) medical-use regulation, layered on state radiation-control rules for the associated CT when a SPECT/CT system is used.

  • Medical use of byproduct material. Possession, dosing, and administration of Tc-99m radiopharmaceuticals are governed by 10 CFR Part 35, with occupational and public dose limits under 10 CFR Part 20, implemented by the facility's radiation safety program and authorized users.
  • Dosimetry basis. ICRP Publication 128 provides the adult effective-dose coefficients used to estimate patient dose and to support ALARA protocol optimization.9
  • Imaging guidelines. The ASNC and SNMMI SPECT MPI guidelines and the EANM procedural guidelines define accepted acquisition, processing, and interpretation practices and are the benchmark used in accreditation.123
  • State and jurisdiction. Radioactive material is regulated by the NRC or the Agreement State; in Florida, materials and radiation-machine requirements are administered under Florida Administrative Code Chapter 64E-5. DRPS also serves Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware, where Agreement State or direct-NRC authorities apply. Always confirm requirements with the authority having jurisdiction.

Frequently Asked Questions (FAQs)

How do Tc-99m sestamibi and tetrofosmin image perfusion?

Both are lipophilic cationic Tc-99m complexes taken up by myocyte mitochondria in proportion to regional blood flow at the time of injection, with minimal redistribution. The image is a snapshot of perfusion, so rest and stress require separate injections.4

What is the difference between sestamibi and tetrofosmin?

They share Tc-99m physics (140 keV, ~6 h) and the same uptake mechanism. Tetrofosmin typically clears liver and lung activity faster, which can permit earlier imaging, and its reported effective-dose coefficients are slightly lower than sestamibi's.49

Why is gated SPECT performed?

Gating yields LVEF, ventricular volumes, and wall motion in addition to perfusion, and it helps distinguish attenuation artifact (preserved wall motion) from true defect.2

What is the radiation dose from a Tc-99m perfusion study?

A conventional one-day rest/stress sestamibi protocol is often about 9 to 12 mSv, while stress-only imaging and CZT cameras with weight-based dosing can reduce effective dose to roughly 2 to 3 mSv.679

Does SPECT measure absolute blood flow?

Standard SPECT shows relative perfusion, and first-pass extraction rolls off at high flow, so hyperemic flow is underestimated. Absolute quantification is more established with PET, though quantitative SPECT continues to advance.14

Key Takeaways

  • Tc-99m sestamibi and tetrofosmin map perfusion by flow-proportional, membrane-potential-driven myocyte uptake with minimal redistribution.4
  • Tc-99m's 140 keV photon and ~6 h half-life are well matched to gamma-camera SPECT.4
  • Gated SPECT adds LVEF, volumes, and wall motion and helps separate artifact from true defect.25
  • CZT dedicated cameras provide roughly 5–10× sensitivity, enabling lower dose or faster scans.18
  • A conventional one-day protocol delivers roughly 12 mSv; stress-only and CZT weight-based protocols can reach ~2–3 mSv.679
  • MPI with byproduct material is regulated under 10 CFR Parts 35 and 20, with ICRP 128 and ASNC/SNMMI/EANM guidelines as the technical basis.1239

How DRPS Can Help

Diagnostic Radiation Physics Services (DRPS) supports nuclear medicine and nuclear cardiology laboratories across Florida, Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware with PET/CT and nuclear medicine physics, accreditation support, and medical physicist consulting — including camera QC, protocol and dose optimization, attenuation-correction commissioning, and radiation safety documentation prepared by board-certified medical physicists.

A strong MPI program is more than a camera and a tracer. It is the disciplined matching of tracer, stress method, acquisition, reconstruction, and dose to the clinical question — done reproducibly and defensibly, patient after patient.

Conclusion

Single-photon myocardial perfusion imaging turns a simple idea — a flow-proportional tracer and a photon a camera can count — into one of the most informative noninvasive tests in cardiology. The quality of the answer depends on the whole chain: tracer choice, stress adequacy, acquisition geometry, gating, attenuation and scatter correction, and dose discipline. Modern tools, especially CZT cameras and stress-only protocols, make it possible to deliver diagnostic images at a fraction of the historical dose. Applied with attention to physics and ALARA, Tc-99m sestamibi and tetrofosmin SPECT remain a durable, high-value foundation of nuclear cardiology.126

Related Resources

References

  1. Henzlova MJ, Duvall WL, Einstein AJ, Travin MI, Verberne HJ. ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers. J Nucl Cardiol. 2016;23(3):606-639. doi:10.1007/s12350-015-0387-x. doi.org
  2. Dorbala S, Ananthasubramaniam K, Armstrong IS, et al. Single Photon Emission Computed Tomography (SPECT) myocardial perfusion imaging guidelines: instrumentation, acquisition, processing, and interpretation. J Nucl Cardiol. 2018;25(5):1784-1846. doi:10.1007/s12350-018-1283-y. doi.org
  3. Verberne HJ, Acampa W, Anagnostopoulos C, et al. EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur J Nucl Med Mol Imaging. 2015;42(12):1929-1940. doi:10.1007/s00259-015-3139-x. doi.org
  4. Caner B, Beller GA. Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability? Clin Cardiol. 1998;21(4):235-242. doi:10.1002/clc.4960210402. doi.org
  5. Gimelli A, Liga R, Clemente A, Marras G, Kusch A, Marzullo P. Left ventricular eccentricity index measured with SPECT myocardial perfusion imaging: an additional parameter of adverse cardiac remodeling. J Nucl Cardiol. 2020;27(1):71-79. doi:10.1007/s12350-017-0777-3. doi.org
  6. van Dijk JD, Borren NM, Mouden M, van Dalen JA, Ottervanger JP, Jager PL. Effect of a patient-specific minimum activity in stress myocardial perfusion imaging using CZT-SPECT: prognostic value, radiation dose, and scan outcome. J Nucl Cardiol. 2018;25(1):26-35. doi:10.1007/s12350-017-1011-z. doi.org
  7. Vitola JV, Mut F, Alexánderson E, et al. Opportunities for improvement on current nuclear cardiology practices and radiation exposure in Latin America: findings from the 65-country IAEA Nuclear Cardiology Protocols cross-sectional study (INCAPS). J Nucl Cardiol. 2017;24(3):851-859. doi:10.1007/s12350-016-0433-3. doi.org
  8. Pourmoghaddas A, Wells RG. Quantitatively accurate activity measurements with a dedicated cardiac SPECT camera: physical phantom experiments. Med Phys. 2016;43(1):44-52. doi:10.1118/1.4937601. doi.org
  9. International Commission on Radiological Protection. Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances. ICRP Publication 128. Ann ICRP. 2015;44(2S). icrp.org